Adeline Vanderver

Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN)

National Institute of Neurological Disorders and Stroke · U54

Contact PI · $12.8M · Children's Hosp of Philadelphia

Interactions Between Diverse Brain Cell Types Drive Aicardi-Goutieres Neuropathology

National Institute of Neurological Disorders and Stroke · R01

PI · $2M · Children's Hosp of Philadelphia

Composite Interferon Signaling Response Biomarker in Aicardi Goutières Syndrome

National Institute of Neurological Disorders and Stroke · R61

Contact PI · $707.3K · Children's Hosp of Philadelphia

GLIA-CTN Genomic Expert Curation Panel

National Institute of Neurological Disorders and Stroke · U24

Contact PI · $1.1M · Children's Hosp of Philadelphia

Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome

Principal investigator · Withdrawn · Phase 1, Phase 2

Children's Hospital of Philadelphia

JAK Inhibitor Treatment in AGS

Principal investigator · Completed · Phase 2

Adeline Vanderver, MD

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Principal investigator · Completed

Children's Hospital of Philadelphia

The Myelin Disorders Biorepository Project

Principal investigator · Recruiting

Children's Hospital of Philadelphia